Martina
Crippa
ab,
Simone
Bersini
a,
Mara
Gilardi
cd,
Chiara
Arrigoni
a,
Sara
Gamba
e,
Anna
Falanga
e,
Christian
Candrian
af,
Gabriele
Dubini
b,
Marco
Vanoni
g and
Matteo
Moretti
*acf
aRegenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), Via Tesserete 46, 6900 Lugano, Switzerland. E-mail: matteo.moretti@eoc.ch
bLaboratory of Biological Structures Mechanics, Chemistry, Material and Chemical Engineering Department “Giulio Natta”, Politecnico di Milano, Milan, Italy
cCell and Tissue Engineering Laboratory, IRCCS Istituto Ortopedico Galeazzi, Via Galeazzi 4, 20161 Milan, Italy
dInstitute of Pathology, University Hospital Basel, University of Basel, 4031 Basel, Switzerland
eDivision of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy
fFacoltà di Scienze Biomediche, Università della Svizzera Italiana, Via Buffi 13, 6900 Lugano, Switzerland
gSYSBIO-ISBE-IT Centre for Systems Biology, Department of Biotechnology and Biosciences, University of Milano Bicocca, Milano, Italy
First published on 9th March 2021
Correction for ‘A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation’ by Martina Crippa et al., Lab Chip, 2021, DOI: 10.1039/d0lc01011a.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |